Compare AWX & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWX | HKPD |
|---|---|---|
| Founded | 1998 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Environmental Services | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 10.6M |
| IPO Year | 1998 | 2025 |
| Metric | AWX | HKPD |
|---|---|---|
| Price | $2.70 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.0K | ★ 137.6K |
| Earning Date | 11-07-2025 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $79,712,000.00 | $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $59.14 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $2.10 | $0.75 |
| 52 Week High | $5.43 | $3.79 |
| Indicator | AWX | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 28.64 |
| Support Level | $2.64 | $0.76 |
| Resistance Level | $2.78 | $0.85 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 62.50 | 4.72 |
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.